Secukinumab is effective in a patient on haemodialysis for end‐stage renal disease and severe hidradenitis suppurativa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secukinumab is effective in a patient on haemodialysis for end‐stage renal disease and severe hidradenitis suppurativa

Published:2024-02-20 Issue:9 Volume:38 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Abu Rached Nessr¹²^ORCID,Ocker Lennart¹²,Stockfleth Eggert¹²,Bechara Falk G.¹²

Affiliation:

1. Department of Dermatology, Venereology and Allergology, International Centre for Hidradenitis Suppurativa/Acne Inversa (ICH) Ruhr‐University Bochum Bochum Germany

2. Skin Cancer Center, Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19868

Reference7 articles.

1. Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis

2. Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease

3. Successful treatment with secukinumab of three psoriatic patients undergoing dialysis

4. Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis

5. The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP